The laboratory’s focus is on the neurons that use glutamate, an excitatory neurotransmitter that is key to the functioning of the central nervous system.

Directed by N.M.K. Ng Ying Kin, PhD, the laboratory measures putative biological markers for various psychiatric conditions and treatment-resistance to usual medications.

Directed by J. Bruno Debruille, MD, PhD, the laboratory attempts to discover the neurocognitive mechanisms of psychotic symptoms of schizophrenia, such as delusions, hallucinations, and alienation.

All laboratory projects require and utilize a multidisciplinary approach, ranging from behavioral models to cellular events, involving the latest technology.

The research team of the neuroimmunology laboratory.

The MGSS conducts research on suicide among aboriginal people.

The research team on service organization and adequacy aims to develop optimum service models in order to improve the quality of the health and social services system.

The lab is using imaging techniques to identify intermediate phenotypes relevant for psychiatric disorders as target phenotypes for gene discovery.

Directed by Véronique Bohbot, PhD, the laboratory focuses on the multiple brain areas involved in processing episodic memories (spatio-temporal information) during navigation.

Directed by Gillian O'Driscoll, PhD, the lab focuses on the neural basis of what are considered "behavioural markers of risk" for schizophrenia.